SCHEMBL622830

SCHEMBL622830

O=C(O)C(OC1CCCCC1)c1ccc(S(=O)(=O)C2CCOCC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL624655 0.99 GCK (0.56) GCK
SCHEMBL11972117 0.94 GCK (0.61) GCK
SCHEMBL624577 0.94 GCK (0.49) GCK
SCHEMBL184712 0.93 GCK (0.62) GCK
SCHEMBL624697 0.93 GCK (0.50) GCK
SCHEMBL623545 0.87 GCK (0.55) GCK
SCHEMBL184935 0.87 GCK (0.56) GCK
SCHEMBL184719 0.87 GCK (0.56) GCK
SCHEMBL184415 0.87 GCK (0.56) GCK
SCHEMBL10141361 0.82 GCK (0.45) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020357-A1 ACETAMIDE COMPOUNDS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS LTD. (IN) 2012-02-16 WO disclosed
WO-2012020357-A1 ACETAMIDE COMPOUNDS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS LTD. (IN) 2012-02-16 WO disclosed